Insider Transactions in Q2 2022 at Sera Prognostics, Inc. (SERA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.71%
|
$1,000
$1.72 P/Share
|
|
Jun 29
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.68%
|
$0
$0.73 P/Share
|
|
Jun 28
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-4.53%
|
$2,725
$1.89 P/Share
|
|
Jun 21
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-4.34%
|
$2,725
$1.31 P/Share
|
|
Jun 14
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-4.15%
|
$2,725
$1.21 P/Share
|
|
Jun 14
2022
|
Benjamin Jackson General Counsel |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$8,000
$1.2 P/Share
|
|
Jun 07
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.99%
|
$2,725
$1.3 P/Share
|
|
Jun 01
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.44%
|
$1,000
$1.36 P/Share
|
|
Jun 01
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.42%
|
$0
$0.73 P/Share
|
|
May 31
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.84%
|
$2,725
$1.45 P/Share
|
|
May 24
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.69%
|
$2,725
$1.54 P/Share
|
|
May 17
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.56%
|
$2,725
$1.55 P/Share
|
|
May 10
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.44%
|
$2,725
$1.97 P/Share
|
|
May 04
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.25%
|
$2,000
$2.17 P/Share
|
|
May 04
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.23%
|
$0
$0.73 P/Share
|
|
May 03
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.33%
|
$5,450
$2.17 P/Share
|
|
Apr 26
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.22%
|
$5,450
$2.17 P/Share
|
|
Apr 19
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.12%
|
$5,450
$2.08 P/Share
|
|
Apr 12
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-3.02%
|
$5,450
$2.66 P/Share
|
|
Apr 06
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.1%
|
$3,000
$3.02 P/Share
|
|
Apr 06
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.09%
|
$0
$0.73 P/Share
|
|
Apr 05
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-2.94%
|
$8,175
$3.35 P/Share
|